Literature DB >> 27322819

Angiotensin II Enhances Proliferation and Inflammation through AT1/PKC/NF-κB Signaling Pathway in Hepatocellular Carcinoma Cells.

Yuanyuan Ji1, Zhidong Wang, Zongfang Li, Aijun Zhang, Yaofeng Jin, Haiyan Chen, Xiaofeng Le.   

Abstract

BACKGROUND/AIMS: The pathogenesis of hepatocellular carcinoma (HCC) is mainly characterized by persistent cycles of liver injury, inflammation, and compensatory hepatocyte proliferation. Angiotensin II (Ang II) behaves as an endogenous pro-inflammatory molecule playing a significant role in HCC, however, the molecular link between Ang II, proliferation and inflammation remains unclear.
METHODS: Human HCC cell lines (HepG-2, SMMC-7721, MHCC97-H) were incubated with Ang II at the indicated concentrations for 24, 48, 72 h. MTT, BrdU ELISA, plate colony formation assay, immunohistochemistry, ELISA, small-interfering RNA(siRNA) transfection, quantitative real-time PCR and western blot were applied to assess their functional, morphological and molecular mechanisms in HCC cell lines.
RESULTS: High expression of Ang II type 1 receptor (AT1) and low expression of AT2 in HCC cells and tissues were found. Next, Ang II could significantly enhance cell growth and proliferation. Albeit Ang II slightly increased the percentage of HCC cells in the G0/G1 phase using flow cytometry analysis, no statistically significant alterations were shown. Further studies suggested that Ang II could directly induce proliferation associated proteins C-myc and proliferating cell nuclear antigen (PCNA) expressions, and inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and C-reactive protein (CRP) productions in HCC cells. Interestingly, blocking AT1 and AT1 siRNA evidently inhibited Ang II-induced cell proliferation and inflammatory responses in HCC cells. More importantly, these effects may be mediated by AT1/PKC/NF-κB signaling pathway in HCC cell lines.
CONCLUSIONS: The results propose that Ang II/AT1/PKC/NF-κB signaling pathway is necessary for proliferation and inflammation of HCC cells, which increases our understanding of the pathogenesis and provides clues for developing new strategies against Ang II-related progress of HCC.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Year:  2016        PMID: 27322819     DOI: 10.1159/000445602

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  10 in total

1.  Biomechanical Forces and Oxidative Stress: Implications for Pulmonary Vascular Disease.

Authors:  Evgeny A Zemskov; Qing Lu; Wojciech Ornatowski; Christina N Klinger; Ankit A Desai; Emin Maltepe; Jason X-J Yuan; Ting Wang; Jeffrey R Fineman; Stephen M Black
Journal:  Antioxid Redox Signal       Date:  2019-03-19       Impact factor: 8.401

2.  Lipopolysaccharide stimulates endogenous β-glucuronidase via PKC/NF-κB/c-myc signaling cascade: a possible factor in hepatolithiasis formation.

Authors:  Dianbo Yao; Qianze Dong; Yu Tian; Chaoliu Dai; Shuodong Wu
Journal:  Mol Cell Biochem       Date:  2017-11-29       Impact factor: 3.396

Review 3.  Integrative Physiological Aspects of Brain RAS in Hypertension.

Authors:  Sharon D B de Morais; Julia Shanks; Irving H Zucker
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

4.  Atmospheric particulate matter2.5 promotes the migration and invasion of hepatocellular carcinoma cells.

Authors:  Qian Zhang; Qiong Luo; Xueyu Yuan; Li Chai; Dan Li; Jianjun Liu; Zhongwei Lv
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

5.  Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma.

Authors:  Long-Hai Feng; Hui-Chuan Sun; Xiao-Dong Zhu; Shi-Zhe Zhang; Xiao-Long Li; Kang-Shuai Li; Xue-Feng Liu; Ming Lei; Yan Li; Zhao-You Tang
Journal:  Ann Transl Med       Date:  2021-02

Review 6.  From dissection of fibrotic pathways to assessment of drug interactions to reduce cardiac fibrosis and heart failure.

Authors:  Gloria Garoffolo; Maurizio Pesce
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-05-25

7.  Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy.

Authors:  Long-Hai Feng; Hui-Chuan Sun; Xiao-Dong Zhu; Shi-Zhe Zhang; Kang-Shuai Li; Xiao-Long Li; Yan Li; Zhao-You Tang
Journal:  Ann Transl Med       Date:  2019-12

8.  AT1 and AT2 Receptor Knockout Changed Osteonectin and Bone Density in Mice in Periodontal Inflammation Experimental Model.

Authors:  Maria Laura de Souza Lima; Caroline Addison Carvalho Xavier de Medeiros; Gerlane Coelho Bernardo Guerra; Robson Santos; Michael Bader; Flavia Q Pirih; Raimundo Fernandes de Araújo Júnior; Alan B Chan; Luis J Cruz; Gerly Anne de Castro Brito; Renata Ferreira de Carvalho Leitão; Ericka Janine Dantas da Silveira; Vinicius Barreto Garcia; Agnes Andrade Martins; Aurigena Antunes de Araújo
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

Review 9.  Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.

Authors:  Matthias Pinter; Rakesh K Jain
Journal:  Sci Transl Med       Date:  2017-10-04       Impact factor: 17.956

10.  The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects.

Authors:  Hirotetsu Takagi; Kosuke Kaji; Norihisa Nishimura; Koji Ishida; Hiroyuki Ogawa; Hiroaki Takaya; Hideto Kawaratani; Kei Moriya; Tadashi Namisaki; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.